Does the time-point of relapse influence outcome in pediatric rhabdomyosarcomas?

Mattke, Adrian C., Bailey, Emily J., Schuck, Andreas, Dantonello, Tobias, Leuschner, Ivo, Klingebiel, Thomas, Treuner, Joern and Koscielniak, Ewa (2009) Does the time-point of relapse influence outcome in pediatric rhabdomyosarcomas?. Pediatric Blood and Cancer, 52 7: 772-776. doi:10.1002/pbc.21906

Author Mattke, Adrian C.
Bailey, Emily J.
Schuck, Andreas
Dantonello, Tobias
Leuschner, Ivo
Klingebiel, Thomas
Treuner, Joern
Koscielniak, Ewa
Title Does the time-point of relapse influence outcome in pediatric rhabdomyosarcomas?
Journal name Pediatric Blood and Cancer   Check publisher's open access policy
ISSN 1545-5009
Publication date 2009-07-01
Sub-type Article (original research)
DOI 10.1002/pbc.21906
Open Access Status
Volume 52
Issue 7
Start page 772
End page 776
Total pages 5
Place of publication Hoboken, NJ, United States
Publisher John Wiley & Sons
Language eng
Formatted abstract
Childhood rhabdomyosarcoma (RMS), a soft tissue malignant tumor of skeletal muscle origin, accounts for approximately 3.5% of the cases of cancer among children 0-14 years and 2% of the cases among adolescents and young adults 15-19 years of age.


We evaluated survival (SUR) after first relapse depending on the time to relapse (TTR) in RMSs of childhood and adolescence. Early, intermediate, and late relapsing patients were evaluated for prognostic risk factors.

Two hundred thirty-four patients with RMS enrolled in the German sarcoma trial CWS-81, CWS-86, CWS-91, and CWS-96 met selection criteria. Of the 234 patients, 35%, 32%, and 33% relapsed within 6 (early), 6-12 (intermediate), and more than 12 (late) months respectively after the end of primary therapy. Four-year SUR was 12%, 21%, and 41% for early, intermediate, and late relapse respectively (P<0.001). Four-year SUR after local relapse was 18% (early), 38% (intermediate), and 49% (late). Embryonal RMS showed four year SUR of 16%, 30%, and 46% (P<0.001) whereas alveolar histology showed four year SUR of 8%, 6%, and 23% (P<0.01) for early, intermediate, and late relapse respectively.


TTR has significant influence on prognosis in relapsed RMS. It influences SUR independent of other features such as type of relapse, histology, tumor site, primary treatment time or irradiation in primary treatment.
Keyword Children
Soft tissue sarcoma
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status Non-UQ

Document type: Journal Article
Sub-type: Article (original research)
Collection: School of Medicine Publications
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 10 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 13 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Thu, 03 Sep 2009, 18:15:25 EST by Mr Andrew Martlew on behalf of Paediatrics & Child Health - RBWH